Biosafe Sepax 2: An innovative solution for automated cell processing
The Sepax 2 from Biosafe embodies technological advancement in the field of automated cell processing. This state-of-the-art device is designed to simplify and secure the processing of stem cells from umbilical cord blood, bone marrow or peripheral blood, while ensuring consistent quality and complete traceability. Thanks to its closed system, the Sepax 2 minimises the risk of contamination and improves the efficiency of clinical and research processes.
The Sepax 2 technology is based on a high-performance separation chamber that combines centrifugation and precise component displacement using an electric motor and a pneumatic circuit. This approach allows the different blood components to be effectively isolated and directed to their respective containers using a sophisticated optical sensor that measures the light absorbance of the separated fractions.
The Sepax 2 user interface is designed to provide an intuitive and interactive experience. The colour touchscreen and active guidance throughout the procedures make it easy even for novice users to follow each step. In addition, an integrated live support function provides solutions in the event of problems, enhancing the safety and reliability of the device.
The Sepax 2's connectivity makes it easy to integrate into modern medical environments. Ethernet and USB ports allow it to be connected to peripherals such as barcode readers and printers for optimal data management. The ability to automatically print detailed reports in PDF format with all traceability identifiers reflects the importance placed on regulatory compliance and patient safety.
Compact and lightweight, the Sepax 2 is easy to transport and install in different clinical environments. It complies with international electrical safety standards (IEC 60601-1) and meets the requirements of Directive 93/42/EEC on medical devices. The device is also CE certified and has FDA 510(k) clearance, ensuring its quality and reliability for global use.